Naima Thavory Joseph, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 10 | 2024 | 2183 | 2.690 |
Why?
|
Homicide | 2 | 2024 | 294 | 1.400 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2024 | 1354 | 1.030 |
Why?
|
Suicide | 2 | 2024 | 1606 | 0.780 |
Why?
|
Pregnancy | 30 | 2024 | 30238 | 0.760 |
Why?
|
Stillbirth | 1 | 2023 | 381 | 0.660 |
Why?
|
Reproductive Medicine | 1 | 2021 | 98 | 0.650 |
Why?
|
Maternal-Fetal Exchange | 1 | 2021 | 454 | 0.640 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 219 | 0.630 |
Why?
|
Antibody Formation | 2 | 2023 | 1392 | 0.580 |
Why?
|
Obstetrics | 1 | 2024 | 679 | 0.560 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2020 | 395 | 0.540 |
Why?
|
Virus Diseases | 1 | 2023 | 722 | 0.540 |
Why?
|
Firearms | 1 | 2024 | 630 | 0.530 |
Why?
|
Maternal Health Services | 1 | 2020 | 472 | 0.470 |
Why?
|
Hydatidiform Mole | 4 | 2016 | 255 | 0.430 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2021 | 2038 | 0.370 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2021 | 529 | 0.370 |
Why?
|
Georgia | 5 | 2022 | 186 | 0.360 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 488 | 0.360 |
Why?
|
Influenza, Human | 1 | 2022 | 1543 | 0.350 |
Why?
|
Papillomavirus Infections | 2 | 2021 | 1639 | 0.340 |
Why?
|
HIV Infections | 3 | 2024 | 17542 | 0.310 |
Why?
|
Pregnancy Outcome | 4 | 2024 | 2972 | 0.290 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7848 | 0.280 |
Why?
|
Female | 36 | 2024 | 396660 | 0.260 |
Why?
|
HIV-1 | 1 | 2022 | 6951 | 0.240 |
Why?
|
Infant, Newborn | 6 | 2024 | 26396 | 0.230 |
Why?
|
Perinatology | 1 | 2023 | 64 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3112 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3234 | 0.200 |
Why?
|
Uterine Neoplasms | 3 | 2016 | 1424 | 0.200 |
Why?
|
HIV Integrase Inhibitors | 1 | 2024 | 165 | 0.200 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2024 | 296 | 0.190 |
Why?
|
Environmental Health | 1 | 2024 | 297 | 0.190 |
Why?
|
Pre-Eclampsia | 2 | 2021 | 1255 | 0.190 |
Why?
|
Humans | 38 | 2024 | 767040 | 0.180 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 136 | 0.180 |
Why?
|
Pandemics | 5 | 2022 | 8736 | 0.170 |
Why?
|
Phthalic Acids | 1 | 2024 | 487 | 0.170 |
Why?
|
Malawi | 1 | 2020 | 312 | 0.160 |
Why?
|
Health Literacy | 1 | 2024 | 466 | 0.160 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 366 | 0.160 |
Why?
|
Parturition | 1 | 2023 | 454 | 0.160 |
Why?
|
Maternal Age | 3 | 2016 | 804 | 0.160 |
Why?
|
International Classification of Diseases | 2 | 2021 | 935 | 0.150 |
Why?
|
Prenatal Care | 2 | 2023 | 1158 | 0.150 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4903 | 0.150 |
Why?
|
Wounds, Gunshot | 1 | 2024 | 586 | 0.150 |
Why?
|
Uganda | 1 | 2021 | 1353 | 0.140 |
Why?
|
Adenine | 1 | 2022 | 995 | 0.130 |
Why?
|
Social Justice | 1 | 2021 | 487 | 0.130 |
Why?
|
Violence | 1 | 2022 | 931 | 0.130 |
Why?
|
Breast Feeding | 1 | 2024 | 1362 | 0.130 |
Why?
|
Young Adult | 10 | 2024 | 59980 | 0.130 |
Why?
|
Urban Population | 2 | 2020 | 2044 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2021 | 1139 | 0.120 |
Why?
|
Viral Load | 1 | 2024 | 3385 | 0.120 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 2011 | 0.120 |
Why?
|
Retrospective Studies | 7 | 2024 | 81659 | 0.120 |
Why?
|
Telemedicine | 2 | 2022 | 3110 | 0.120 |
Why?
|
Quality of Health Care | 2 | 2020 | 4306 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11872 | 0.110 |
Why?
|
Outpatients | 1 | 2022 | 1600 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2023 | 3070 | 0.110 |
Why?
|
Organoplatinum Compounds | 1 | 2015 | 406 | 0.110 |
Why?
|
Vaccination | 2 | 2023 | 3434 | 0.100 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1787 | 0.100 |
Why?
|
Health Services Research | 1 | 2020 | 1815 | 0.100 |
Why?
|
Population Surveillance | 1 | 2022 | 2594 | 0.100 |
Why?
|
Cause of Death | 1 | 2022 | 3717 | 0.100 |
Why?
|
Cesarean Section | 1 | 2020 | 1419 | 0.100 |
Why?
|
Anti-HIV Agents | 2 | 2024 | 4567 | 0.090 |
Why?
|
Cohort Studies | 4 | 2021 | 41718 | 0.090 |
Why?
|
Diabetes, Gestational | 1 | 2021 | 1263 | 0.090 |
Why?
|
Adult | 14 | 2024 | 223317 | 0.090 |
Why?
|
Hospitals, Public | 2 | 2022 | 204 | 0.090 |
Why?
|
Neutropenia | 1 | 2015 | 892 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1882 | 0.080 |
Why?
|
Prospective Studies | 3 | 2023 | 54886 | 0.080 |
Why?
|
United States | 5 | 2024 | 72971 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3236 | 0.070 |
Why?
|
Mortality | 1 | 2018 | 2909 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4855 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7435 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3552 | 0.070 |
Why?
|
Vaginal Smears | 1 | 2009 | 505 | 0.070 |
Why?
|
Infant | 3 | 2023 | 36485 | 0.060 |
Why?
|
Communication Barriers | 1 | 2009 | 419 | 0.060 |
Why?
|
Anemia | 1 | 2015 | 1514 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 13048 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6844 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15851 | 0.050 |
Why?
|
Attitude to Health | 2 | 2009 | 2023 | 0.050 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2022 | 27 | 0.050 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 168 | 0.050 |
Why?
|
Papillomavirus Vaccines | 1 | 2009 | 497 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39317 | 0.050 |
Why?
|
Amides | 1 | 2024 | 451 | 0.050 |
Why?
|
Adolescent | 5 | 2024 | 89046 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3212 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26325 | 0.050 |
Why?
|
Reproductive Rights | 1 | 2021 | 31 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12823 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5363 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12536 | 0.040 |
Why?
|
Pyridones | 1 | 2024 | 819 | 0.040 |
Why?
|
Medically Underserved Area | 1 | 2020 | 268 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18401 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2022 | 643 | 0.040 |
Why?
|
Demography | 1 | 2021 | 1641 | 0.030 |
Why?
|
Gravidity | 1 | 2016 | 50 | 0.030 |
Why?
|
Medical Records | 1 | 2021 | 1409 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1271 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2419 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3232 | 0.030 |
Why?
|
Postpartum Period | 1 | 2021 | 1198 | 0.030 |
Why?
|
Piperazines | 1 | 2024 | 2548 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1726 | 0.030 |
Why?
|
Mass Screening | 1 | 2009 | 5456 | 0.030 |
Why?
|
Parity | 1 | 2016 | 931 | 0.030 |
Why?
|
New England | 1 | 2016 | 1058 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2870 | 0.030 |
Why?
|
Chorionic Gonadotropin | 1 | 2014 | 458 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2015 | 59548 | 0.020 |
Why?
|
Alleles | 1 | 2022 | 6893 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3387 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4560 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13491 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2024 | 4546 | 0.020 |
Why?
|
Aged | 3 | 2018 | 171319 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3883 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12793 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9245 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8531 | 0.020 |
Why?
|
Culture | 1 | 2009 | 622 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21526 | 0.010 |
Why?
|
Child | 2 | 2023 | 80771 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10815 | 0.010 |
Why?
|
Risk Factors | 3 | 2016 | 74886 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3321 | 0.010 |
Why?
|
Language | 1 | 2009 | 1550 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11217 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42606 | 0.010 |
Why?
|
Middle Aged | 3 | 2018 | 223233 | 0.010 |
Why?
|
Male | 2 | 2024 | 364203 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2009 | 3414 | 0.010 |
Why?
|
Prognosis | 1 | 2014 | 29963 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2009 | 5519 | 0.010 |
Why?
|
Animals | 1 | 2014 | 168965 | 0.000 |
Why?
|